288 related articles for article (PubMed ID: 32485991)
1. Protective Effect of Angiotensin 1-7 on Sarcopenia Induced by Chronic Liver Disease in Mice.
Aguirre F; Abrigo J; Gonzalez F; Gonzalez A; Simon F; Cabello-Verrugio C
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485991
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin-proteasome system and oxidative stress.
Campos F; Abrigo J; Aguirre F; Garcés B; Arrese M; Karpen S; Cabrera D; Andía ME; Simon F; Cabello-Verrugio C
Pflugers Arch; 2018 Oct; 470(10):1503-1519. PubMed ID: 29926227
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.
Morales MG; Abrigo J; Acuña MJ; Santos RA; Bader M; Brandan E; Simon F; Olguin H; Cabrera D; Cabello-Verrugio C
Dis Model Mech; 2016 Apr; 9(4):441-9. PubMed ID: 26851244
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin (1-7) Decreases Myostatin-Induced NF-κB Signaling and Skeletal Muscle Atrophy.
Aravena J; Abrigo J; Gonzalez F; Aguirre F; Gonzalez A; Simon F; Cabello-Verrugio C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050585
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-β) via Mas Receptor Activation.
Ábrigo J; Simon F; Cabrera D; Cabello-Verrugio C
Cell Physiol Biochem; 2016; 40(1-2):27-38. PubMed ID: 27842312
[TBL] [Abstract][Full Text] [Related]
7. The complex of PAMAM-OH dendrimer with Angiotensin (1-7) prevented the disuse-induced skeletal muscle atrophy in mice.
Márquez-Miranda V; Abrigo J; Rivera JC; Araya-Durán I; Aravena J; Simon F; Pacheco N; González-Nilo FD; Cabello-Verrugio C
Int J Nanomedicine; 2017; 12():1985-1999. PubMed ID: 28331320
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin-induced skeletal muscle wasting is prevented by angiotensin-(1-7) through a p38 MAPK-dependent mechanism.
Morales MG; Olguín H; Di Capua G; Brandan E; Simon F; Cabello-Verrugio C
Clin Sci (Lond); 2015 Sep; 129(6):461-76. PubMed ID: 25989282
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5.
Abrigo J; Campos F; Gonzalez F; Aguirre F; Gonzalez A; Huerta-Salgado C; Conejeros S; Simon F; Arrese M; Cabrera D; Elorza AA; Cabello-Verrugio C
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33113850
[TBL] [Abstract][Full Text] [Related]
10. N-Acetyl Cysteine Attenuates the Sarcopenia and Muscle Apoptosis Induced by Chronic Liver Disease.
Abrigo J; Marín T; Aguirre F; Tacchi F; Vilos C; Simon F; Arrese M; Cabrera D; Cabello-Verrugio C
Curr Mol Med; 2019; 20(1):60-71. PubMed ID: 31530262
[TBL] [Abstract][Full Text] [Related]
11. Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor.
Abrigo J; Gonzalez F; Aguirre F; Tacchi F; Gonzalez A; Meza MP; Simon F; Cabrera D; Arrese M; Karpen S; Cabello-Verrugio C
J Cell Physiol; 2021 Jan; 236(1):260-272. PubMed ID: 32506638
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice.
Meneses C; Morales MG; Abrigo J; Simon F; Brandan E; Cabello-Verrugio C
Pflugers Arch; 2015 Sep; 467(9):1975-84. PubMed ID: 25292283
[TBL] [Abstract][Full Text] [Related]
14. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7) Prevents Lipopolysaccharide-Induced Autophagy via the Mas Receptor in Skeletal Muscle.
Rivera JC; Abrigo J; Tacchi F; Simon F; Brandan E; Santos RA; Bader M; Chiong M; Cabello-Verrugio C
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302427
[TBL] [Abstract][Full Text] [Related]
16. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass.
Rom O; Reznick AZ
Free Radic Biol Med; 2016 Sep; 98():218-230. PubMed ID: 26738803
[TBL] [Abstract][Full Text] [Related]
17. An ethanolic extract of Artemisia dracunculus L. regulates gene expression of ubiquitin-proteasome system enzymes in skeletal muscle: potential role in the treatment of sarcopenic obesity.
Kirk-Ballard H; Kilroy G; Day BC; Wang ZQ; Ribnicky DM; Cefalu WT; Floyd ZE
Nutrition; 2014; 30(7-8 Suppl):S21-5. PubMed ID: 24985101
[TBL] [Abstract][Full Text] [Related]
18. Atrogin-1, MuRF-1, and sarcopenia.
Gumucio JP; Mendias CL
Endocrine; 2013 Feb; 43(1):12-21. PubMed ID: 22815045
[TBL] [Abstract][Full Text] [Related]
19. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
20. MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD.
Natanek SA; Riddoch-Contreras J; Marsh GS; Hopkinson NS; Moxham J; Man WD; Kemp PR; Polkey MI
COPD; 2013 Oct; 10(5):618-24. PubMed ID: 23844868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
